Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines.
Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines.
复制标题
为什么我们关心冠状动脉微血管功能障碍和射血分数保留的心力衰竭:解决循证指南的知识差距。
DOI:
10.1093/eurheartj/ehy558
复制
发表时间:
2018
影响因子:
39.3
通讯作者:
BaireyMerz,CNoel
中科院分区:
文献类型:
--
作者:
Wei,Janet;Nelson,MichaelD;Sharif,Behzad;Shufelt,Chrisandra;BaireyMerz,CNoel
There is increasing documentation that coronary microvascular dysfunction (CMD)-related subendocardial ischaemia contributes to left ventricular remodeling, diastolic and systolic dysfunction, and subsequent heart failure with preserved ejection fraction (HFpEF). 1 To date, prevalence of microvascular dysfunction in heart failure with preserved ejection fraction (PROMIS-HFpEF)(n= 202) is the largest prospective, multicentre study (Scandinavia, USA, and Singapore) evaluating coronary flow reserve (CFR), a diagnostic measure of CMD, in subjects with known HFpEF. 2 In this study, 75% of the subjects had evidence of CMD, defined as CFR< 2.5 measured by adenosine stress transthoracic Doppler echocardiography. The investigators found that low CFR is associated with elevated N-terminal pro b-type natriuretic peptide (NTproBNP), and abnormal cardiac structure and function including left atrial and right ventricular (RV) dysfunction. Shah et al. also report that low CFR is associated with peripheral endothelial dysfunction, as measured by reactive hyperemia index (RHI). While other studies have reported peripheral vascular dysfunction in patients with HFpEF, 3 the PROMIS-HFpEF investigators are the first to document an association with CFR. Specifically, low CFR is more strongly associated with low RHI in obesity, suggesting that HFpEF is a systemic vascular disorder that potentially impacts other organs.